Background The rising concern of irreproducible and non-transparent studies poses a
significant challenge in modern medical literature. The impact of this issue on cardiology …

ABSTRACT Background Randomized controlled trials (RCTs) may report outcomes different
from those prespecified on trial-registration websites, protocols and statistical analysis plans …

Abstract Background Patient reported outcomes (PROs) are important measures of health,
particularly in symptomatic conditions such as heart failure (HF), and regulatory agencies …

The European Society of Cardiology (ESC) Congress 2021, although still online due to the
Covid-19 pandemic, was an extraordinary theatre for the presentation of practice-changing …

Background: Assessment of heterogeneity in meta-analyses is critical to ensure the
consistency of pooled results. Therefore, we sought to assess the evaluation and reporting …

Background Patient‐reported outcomes (PROs) are important measures of treatment
response in heart failure. We assessed temporal trends in and factors associated with …

Objectives It has been suggested that biomedical research is facing a reproducibility issue,
yet the extent of reproducible research within the cardiology literature remains unclear …

The Task Force for the diagnosis and treatment of acute and chronic heart failure (HF) of the
European Society of Cardiology (ESC) generally updates their guidelines every 4 years …

Background Several fields have described low reproducibility of scientific research and poor
accessibility in research reporting practices. Although previous reports have investigated …

Importance Transparency and data sharing are valuable practices in research, contributing
to improved precision and flexibility in cumulative evidence; and ultimately expanding the …